Loading...

Minimal clinically important difference in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease with an estimated median survival of 2–5 years and a significant impact on quality of life (QoL). Current approved medications, pirfenidone and nintedanib, have shown a reduction in annual decline of forced vital ca...

Full description

Saved in:
Bibliographic Details
Published in:Breathe (Sheff)
Main Authors: Kang, Mohleen, Marts, Lucian, Kempker, Jordan A., Veeraraghavan, Srihari
Format: Artigo
Language:Inglês
Published: European Respiratory Society 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8291912/
https://ncbi.nlm.nih.gov/pubmed/34295421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0345-2020
Tags: Add Tag
No Tags, Be the first to tag this record!